Jung Sun Kim, Gyeong-Won Lee, Myungwon Lee, Jeonghwan Youk, Hyunjung Lee, Sung-Nam Lim, Soyeon Kim, Yoon Kyung Jeon, Chul-Kee Park, Tae Min Kim. "SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)—The Korean Cancer Study Group LY22-07.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.2009